WMD.X
Recent Headlines
- WeedMD Announces Amendments to Existing Credit Facility
- WeedMD Reaffirms Record Q1 2020 Preliminary Net Revenues of $12 Million and Confirms Earnings Call on July 15, 2020
- WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
- When Will WeedMD Inc. (CVE:WMD) Become Profitable?
- WeedMD Launches Same-Day Medical Cannabis Delivery Service
- WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries
- WeedMD Reports Fiscal Year 2019 Financial Results and First Quarter 2020 Preliminary Revenue of $12 Million
- WeedMD to File First Quarter 2020 Financials on or Before July 15
- WeedMD Realigns Reporting Dates and Confirms Fiscal Year 2019 Financials to be Filed After Market on June 10, 2020
- WeedMD to Present in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference on May 12th at 8:40 a.m. ET
- WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020
- WeedMD Kicks-off Second Season of Outdoor Cannabis Cultivation
- WeedMD Responds to UFCW Canada
- WeedMD Announces Appointment of New Chief Financial Officer
- WeedMD Posts Open Letter to Shareholders and Corporate Update from Newly-Appointed CEO
- WeedMD Subsidiary Starseed Medicinal Signs the International Association of Heat and Frost Insulators and Allied Workers Local 95 to its Medical Cannabis Program
- WeedMD Subsidiary Starseed Medicinal Signs the International Union of Painters and Allied Trades to Medical Cannabis Program
- WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada
- WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program
- WeedMD Wins Award for London’s Best Places to Work 2020
- WeedMD Shareholders Approve the $25 Million Strategic Equity Investment, Subscription Receipts Exercise from LiUNA Pension Fund
- WeedMD Announces Leadership Change and Appoints New CEO as Company Accelerates Growth Initiatives
- WeedMD to Hold Special Meeting of Shareholders on February 4th, 2020 at 10:00 a.m. to Finalize $25M Strategic Equity Investment
- WeedMD Subsidiary Starseed Medicinal Signs LiUNA’s London, Ontario Local to Medical Cannabis Program
- WeedMD Closes Acquisition of Starseed Holdings Inc. and $25 Million Subscription Receipt Financing
- Cannabis Earnings Roundup: 4Front, WeedMD, FSD Pharma, 1933 Industries, True Leaf
- WeedMD Posts Open Letter to Shareholders
- IIROC Trading Resumption - WMD
- WeedMD Announces Strategic Combination with Starseed Holdings Inc. and Secures $25 Million Cornerstone Investment
- WeedMD Reports Third Quarter 2019 Financial Results and Announces Strategic Combination with Starseed
- WeedMD Changes Third Quarter 2019 Earnings Conference Call Time to 1 p.m. EST on November 29th
- IIROC Trading Halt - WMD
- WeedMD Appoints Seasoned Management Team to Lead Commercial Extraction Affiliate CX Industries Inc.
- WeedMD to Host Third Quarter 2019 Earnings Conference Call on November 29 at 10 a.m. Eastern Time
- Investor Ideas Cannabis Potcasts Releases Insight from Thought Leaders on the Cannabis Market in North America and Globally
- Investor Ideas Cannabis Potcasts: Podcast Interview with Keith Merker, CEO of WeedMD Inc.
- WeedMD Provides Corporate Update and Schedules Q3 2019 Earnings Call for November 29th
- WeedMD Secures Health Canada Licence for 50,000-Square-Foot Purpose-Built Cannabis Processing Facility
- Strainprint® Technologies Continues to Grow its Network of Medical Cannabis Subscribers with the Addition of WeedMD
- WeedMD to Host Media and VIP Open House to Showcase Harvest of its Outdoor-Cultivated Cannabis
- WeedMD Wraps $13.12-Million Bought-Deal Offering
- WeedMD Closes its $13.1 Million Bought-Deal Offering
- WeedMD Announces Upsize of its Previously Announced Bought-Deal Offering of Convertible Debenture Units to $12 Million
- IIROC Trading Halt - WMD
- WeedMD Announces $10 Million Bought Short Form Prospectus Offering of Convertible Debenture Units
- WeedMD Reports Second Quarter 2019 Financial Results
- WeedMD Assists in Completing Phase 1 of Shoppers Drug Mart & TruTrace's Medical Cannabis Verification Pilot
- WeedMD Reports Preliminary Q2 Net Revenues of $8 Million and Confirms Earnings Call on August 29, 2019
- WeedMD Secures Health Canada Approval for 20 Additional Cannabis Cultivation and Processing Rooms
- CX Industries Signs Exclusive Agreement with Ignite International Brands to Supply Premium Cannabis and CBD Products